Clinical trial
Liposomal Vincristine for Pediatric and Adolescent Patients With Relapsed…
NCT00038207 · M.D. Anderson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00038207 |
|---|---|
| Title | Liposomal Vincristine for Pediatric and Adolescent Patients With Relapsed Malignancies |
| Official title | Phase II Liposomal Vincristine for Pediatric and Adolescent Patients With Relapsed Malignancies |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Collaborators | Inex Pharmaceuticals Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Soft Tissue Sarcoma, Lymphoma, Leukemia, Wilms' Tumor, Osteosarcoma |
| Intervention type | Drug |
| Interventions | Liposomal Vincristine |
| Enrollment | 29 |
| Start date | Jun 1, 2000 |
| Primary completion | Sep 1, 2004 |
| Completion | Sep 1, 2005 |
| First posted | May 30, 2002 |
| Last update posted | Oct 31, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: